“A pronounced double-standard exists in the way that men and women donors are valued by the fertility industry, and it can’t be explained medically or by market forces,” Almeling said. “Based on the availability of donors alone, you would expect the abundance of potential egg donors to drive down compensation fees and the scarcity of potential sperm donors to drive up their fees. But I found just the opposite.”
Another possible example: sperm vs. egg donation.